Home
About us
Editorial board
Ahead of print
Browse Articles
Search
Submit article
Instructions
Subscribe
Contacts
Login
Advanced Search
Users Online: 676
» Articles published in the past year
To view other articles click corresponding year from the navigation links on the left side.
All
|
Case Report
|
Case Reports
|
Editorial
|
Erratum
|
Letter To Editor
|
Letters to Editor
|
Mini Review
|
Notice of Retraction
|
Original Article
|
Original Articles
|
Review Article
|
Review Articles
|
Short Communication
|
Short Communications
|
Systematic Review
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Show all abstracts
Show selected abstracts
Export selected to
Add to my list
Original Article:
Alendronate slows down aortic stenosis progression in osteoporotic patients: An observational prospective study
Gholamhossein Alishiri, Kiyan Heshmat-Ghahdarijani, Mohammad Hashemi, Reihaneh Zavar, Maryam Moshkani Farahani
J Res Med Sci
2020, 25:65 (30 June 2020)
DOI
:10.4103/jrms.JRMS_408_20
Background:
Aortic stenosis (AS) is the most common primary valvular disease. Currently, there is no pharmacological approach for the medical management of AS. We investigated the effect of osteoporosis therapy with alendronate on hemodynamic progression in patients concurrently affected by AS and osteoporosis.
Materials and Methods:
In this observational prospective study, we enrolled 37 women more than 60 years old with diagnosis of AS and concurrent osteoporosis from August 2017 to December 2019. These patients were treated with alendronate 70 mg every week added to their routine treatment for AS, and their outcomes were compared with 33 patients only affected by AS. Echocardiographic changes and N-terminal-prohormone of brain natriuretic peptide (NT-pro-BNP) level were evaluated during about 2 years of follow-up.
Results:
The mean follow-up time for the treated and nontreated groups was 20.89 ± 2.73 and 20.84 ± 2.76 months, respectively. Mean gradient (
P
= 0.02) and peak gradient (
P
= 0.04) of aortic valve were significantly different between the groups after follow-up. Aortic valve area was decreased 0.09 cm
2
in the treated group by alendronate and 0.23 cm
2
in the other group (
P
= 0.001). Furthermore, NT-pro-BNP was significantly decreased in patients treated by alendronate (
P
= 0.01), but it was increased in nontreated patients (
P
= 0.04).
Conclusion:
Treatment with alendronate in patients with AS and concurrent osteoporosis slows down the progression of stenosis and improves their prognosis. This study could open a new pathway for the treatment of AS. Further studies, particularly randomized controlled clinical trial, should be done for providing more evidence.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (2) ]
[Sword Plugin for Repository]
Beta
Original Article:
Relationships between severity of steatosis with glycemic control and carotid intima-media thickness among diabetic patients with ischemic heart disease
Nurazam Omar, Marymol Koshy, Mohammad Hanafiah, Sharifah Faradilla Wan Muhammad Hatta, Fatimah Zaherah Mohd Shah, Bushra Johari, Idris Zamhuri, Sazzli Shahlan Kasim, Thuhairah Abdul Rahman, Rohana Abdul Ghani
J Res Med Sci
2020, 25:64 (30 June 2020)
DOI
:10.4103/jrms.JRMS_560_17
Background:
Nonalcoholic fatty liver disease (NAFLD) has become one of the major diseases plaguing worldwide. Several studies reported its association with ischemic heart disease (IHD). This study aims to determine the relationships between severity of steatosis with glycemic control and carotid intima-media thickness (CIMT) among a high-risk population of type 2 diabetes mellitus (T2DM) with proven IHD.
Materials and Methods:
This was a cross-sectional study involving patients aged between 18 and 65 years diagnosed with T2DM with IHD (
n
= 150). Ultrasonography of the abdomen to determine NAFLD severity category and CIMT measurements was performed by two independent radiologists. NAFLD was graded according to the severity of steatosis (NAFLD-3, NAFLD-2, NAFLD-1, and NAFLD-0). Comparison between different stages of NAFLD (NAFLD-3, NAFLD-2, NAFLD-1, and NAFLD-0) was analyzed using Chi-square and analysis of variance tests for categorical and continuous variables, respectively.
Results:
The prevalence of NAFLD was 71% (
n
= 107). NAFLD-1 was detected in 39% of the patients, 32% had NAFLD-2, no patients with NAFLD-3, and 29% had non-NAFLD. There were no patients with NAFLD-2 having higher systolic and diastolic blood pressure, weight, body mass index, waist circumference, total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol. Glycated hemoglobin (HbA1c) concentration was highest within the NAFLD-2. NAFLD-2 showed higher mean CIMT. Every 1% rise in HbA1c for patients with NAFLD significantly increases the CIMT by 0.03 mm (95% CI: 0.009, 0.052,
P
= 0.006).
Conclusion:
These findings suggest additional atherosclerotic risks within the NAFLD-2 group with significantly higher HbA1c and CIMT compared to the NAFLD-1 and NAFLD-0 groups. It is, therefore, vital to incorporate stricter glycemic control among patients with T2DM and IHD with moderate NAFLD as part of atherosclerotic risk management strategy.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (2) ]
[Sword Plugin for Repository]
Beta
Original Article:
The sequential assay of interleukin-10 and 13 serum levels in relation to radiographic changes during pulmonary tuberculosis treatment
Sayyed Gholamreza Mortazavi Moghaddam, Mohammad Hasan Namaei, Reza Eslami Manoochehri, Mahmood Zardast
J Res Med Sci
2020, 25:63 (30 June 2020)
DOI
:10.4103/jrms.JRMS_116_19
Background:
We evaluated the sequential changes of interleukin (IL)-10 and IL-13 serum levels with tuberculosis (TB)-related radiographic changes during pulmonary TB (PTB) treatment.
Materials and Methods:
In this cross-sectional study during two consecutive years, forty cases with PTB were recorded, and finally, 24 cases were completed the study. Serum levels of IL-10 and IL-13 were measured on admission time, and 6 months later. Furthermore, chest radiography was performed on admission and 6 months later in the treatment course.
Results:
Radiography at the baseline indicated pulmonary infiltration in all patients (
n
= 24). Fifteen (62.5%) cases had abnormal and 9 (37.5%) cases had normal radiography at the end of 6 months treatment course. IL-10 and IL-13 upregulated during the treatment time course, and their relationship with radiographic changes shifted from negative (
r
= −0.14 and
P
= 0.71) on admission to positive (
r
= 0.80 and
P
< 0.001) at the end of 6 months treatment course in normal radiography group. IL-10 level at the start of the treatment was 121.90 ± 88.81 in patients with normal and 82.68 ± 41.50 in patients with abnormal radiography (
P
= 0.31).
Conclusion:
Sequential increase in IL-10 and IL-13 during PTB treatment course may have a role in clearing the TB-related radiographic infiltration and preventing scar formation.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Sword Plugin for Repository]
Beta
Original Article:
Comparison of dialectical behavior therapy and anti-anxiety medication on anxiety and digestive symptoms in patients with functional dyspepsia
Tahmine Tavakoli, Masoud Hoseini, Toktam Sadat Jafar Tabatabaee, Zeinab Rostami, Homa Mollaei, Afsane Bahrami, Sara Ayati, Bita Bijari
J Res Med Sci
2020, 25:59 (30 June 2020)
DOI
:10.4103/jrms.JRMS_673_19
Background:
Functional dyspepsia is a common chronic digestive disorder. The purpose of this study was to compare the effectiveness of dialectical behavior therapy and anti-anxiety medication in patients with functional dyspepsia.
Materials and Methods:
The present study was a randomized, controlled clinical trial with sixty patients who were suffering from functional dyspepsia that identified by the ROME III criteria. Patients were divided into three groups by using pre- and posttest design, including Group A (dialectal treatment and pantoprazole), Group B (anxiolytic drug treatment and pantoprazole), and Group C (no intervention, only pantoprazole were used). The Beck Anxiety Inventory and the patient assessment of Gastrointestinal Symptom Severity Index Questionnaire were completed by the patients after receiving the written consent. Finally, the data were analyzed using the Statistical Package for the Social Sciences software version 20.
Results:
There was a significant improvement in the severity of dyspepsia after intervention in all three groups. The greatest decrease in the severity of functional dyspepsia was observed in the dialectical behavioral therapy group as compared to the other groups (Group A: −15.4 ± 6.61, Group B: −3.85 ± 2.77, and Group C: −7.8 ± 4.02;
P
= 0.001). Furthermore, the Beck Anxiety Inventory scores were statistically significantly improved in all three groups (Group A: −5.75 ± 2.53, Group B: −7.3 ± 3.19, and Group C: −2.60 ± 1.5;
P
= 0.001). There was a positive correlation between the change in dyspepsia score and change in anxiety score across different intervention groups (
r
= 0.55;
P
< 0.001).
Conclusion:
Dialectical behavioral therapy can be effective in reducing anxiety and improving the dyspepsia symptoms in patients with functional dyspepsia compared to anti-anxiety medication or conventional therapy. Therefore, communication between the physicians and psychologists and psychiatrists can have positive effects on the treatment of these patients.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (6) ]
[Sword Plugin for Repository]
Beta
Original Article:
Could preoperative sonographic criteria predict the difficulty of laparoscopic cholecystectomy?
Taghi Jalil, Atoosa Adibi, Mohsen Mahmoudieh, Behrouz Keleidari
J Res Med Sci
2020, 25:57 (30 June 2020)
DOI
:10.4103/jrms.JRMS_345_19
Background:
Although laparoscopic cholecystectomy (LC) is the gold standard approach for gallbladder diseases, this sometimes may face difficulties and require conversion to open surgery. The preoperative ultrasonographic study may provide information about the probability of difficult LC, but the data in this term are uncertain. We assessed the value of preoperative ultrasonographic findings for the prediction of LC's difficulty.
Materials and Methods:
The current prospective clinical trial was conducted on 150 patients who were candidates for LC due to symptomatic gallstone. All of the patients underwent ultrasonography study preoperatively, and then, LC was performed. The surgeon completed a checklist regarding the easy or difficult surgical criteria. Finally, the values of ultrasonographic findings for the prediction of LC difficulty were evaluated.
Results:
Among the 150 included patients, 80 had easy LC and 70 had difficult LC. Statistically significant differences were found between the two groups of easy and difficult LC regarding gallbladder wall thickness (
P
= 0.008), stone impaction (
P
= 0.009), and gallbladder flow (
P
= 0.04). The area under the curve (standard error [SE]) for the thickness of the gallbladder wall, flow in the gallbladder wall, and stone impaction was 0.598 ± 0.048, 0.543 ± 0.047, and 0.554 ± 0.047, respectively (
P
< 0.05). The highest specificity was for gallbladder wall flow (100%). Binary logistic regression showed that stone impaction had predictive value for determining difficult LC (odds ratio = 3.10; 95% confidence interval: 1.03–9.30;
P
= 0.04).
Conclusion:
Although a significant difference was observed between two groups in terms of impacted stone, flow in the gallbladder wall, and thickness of the gallbladder wall, only stone impaction had predictive value for determining difficult LC.
[ABSTRACT]
[HTML Full text]
[PDF]
[Mobile Full text]
[EPub]
[Citations (1) ]
[Sword Plugin for Repository]
Beta
Advanced Search
Month wise articles
Figures next to the month indicate the number of articles in that month
2023
March
[
3
]
February
[
2
]
January
[
3
]
2022
December
[
4
]
November
[
5
]
September
[
6
]
August
[
6
]
July
[
6
]
June
[
4
]
May
[
4
]
April
[
6
]
March
[
6
]
February
[
8
]
January
[
7
]
2021
November
[
5
]
October
[
9
]
September
[
6
]
August
[
11
]
July
[
5
]
June
[
4
]
May
[
4
]
March
[
2
]
February
[
5
]
January
[
7
]
2020
December
[
5
]
November
[
4
]
October
[
7
]
September
[
6
]
August
[
5
]
July
[
5
]
June
[
5
]
May
[
7
]
April
[
7
]
March
[
8
]
February
[
6
]
January
[
8
]
2019
December
[
6
]
November
[
6
]
October
[
6
]
September
[
5
]
August
[
4
]
July
[
11
]
June
[
5
]
May
[
9
]
April
[
5
]
March
[
5
]
February
[
6
]
January
[
5
]
2018
December
[
7
]
November
[
6
]
October
[
4
]
September
[
5
]
August
[
6
]
July
[
7
]
June
[
6
]
May
[
8
]
March
[
3
]
February
[
6
]
January
[
6
]
2017
December
[
4
]
November
[
2
]
June
[
7
]
1900
January
[
1
]
Sitemap
|
What's New
Feedback
|
Copyright and Disclaimer
|
Privacy Notice
© Journal of Research in Medical Sciences | Published by Wolters Kluwer -
Medknow
Online since 9
th
February, 2015